Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminomaJ Aparicio, X García del Muro, P Maroto, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 23, 2020
Latest progress in molecular biology and treatment in genitourinary tumoursA González-Del-Alba, J Á Arranz, J Bellmunt, et al.
ESMO Open|August 30, 2024
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II studyA Rodriguez-Vida, B P Valderrama, D Castellano, et al.
The Journal of Urology|June 5, 2019
Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer GroupJ Aparicio, A Sánchez-Muñoz, S Ochenduszko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2014
Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)J Aparicio, P Maroto, X García Del Muro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 11, 2014
Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data baseR Girones, J Aparicio, P Roure, et al.
European Urology|December 13, 2002
Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG)J R Germà-Lluch, X Garcia del Muro, P Maroto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2026
Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancerS Gillessen, E Gallardo, A Choudhury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2025
Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trialB Tombal, A Choudhury, F Saad, et al.
ESMO Open|August 12, 2025
Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinomaM S van der Heijden, T Powles, S Gupta, et al.
Pageof 6